Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists probe Body's chemistry to unlock PAH mysteries

NCT ID NCT01884051

First seen Oct 01, 2025 · Last updated Jun 11, 2026 · Updated 31 times

Summary

This study looks at how hormones and metabolism are linked to pulmonary arterial hypertension (PAH), a serious lung condition. Researchers will measure things like sex hormone levels and insulin resistance in up to 1,899 people, including patients, healthy volunteers, and family members. The goal is to find new ways to treat PAH by targeting these underlying pathways.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

Conditions

The condition(s) this trial relates to.

Familial Primary Pulmonary Hypertension pulmonary arterial hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.